COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥10 | CN¥12 | CN¥16 | CN¥20 |
| - Cash | CN¥2 | CN¥1 | CN¥1 | CN¥1 |
| + Debt | CN¥4 | CN¥4 | CN¥3 | CN¥3 |
| Enterprise Value | CN¥13 | CN¥15 | CN¥18 | CN¥23 |
| Revenue | CN¥20 | CN¥20 | CN¥20 | CN¥24 |
| % Growth | -1.6% | 2.3% | -15.5% | – |
| Gross Profit | CN¥1 | CN¥1 | CN¥2 | CN¥2 |
| % Margin | 5.7% | 2.9% | 10.4% | 10.3% |
| EBITDA | CN¥1 | CN¥0 | CN¥2 | CN¥2 |
| % Margin | 3% | 0.2% | 9.9% | 9% |
| Net Income | CN¥0 | -CN¥1 | CN¥1 | CN¥1 |
| % Margin | 0.1% | -3% | 5.3% | 4.8% |
| EPS Diluted | 0.014 | -0.327 | 0.57 | 0.605 |
| % Growth | 104.1% | -157.3% | -5.8% | – |
| Operating Cash Flow | CN¥0 | CN¥2 | CN¥1 | CN¥5 |
| Capital Expenditures | -CN¥0 | -CN¥1 | -CN¥1 | -CN¥1 |
| Free Cash Flow | -CN¥0 | CN¥1 | CN¥0 | CN¥4 |